Editor
in Chief :
Mahmoud
Ashraf Ibrahim ,MD |
|
Issues
per Volume:
Quarterly
Current Volume: 1
Current Issue : 1
|
Volume
1 number 1 Summer 2003
Special issue for the abstracts of the 7th Pan Arab Conference
on Diabetes
PACD7 , 25 – 28 March 2003 Cairo
Abstract Number : 10
DYSLIPIDEMIA AND TYPE-2 DIABETICS
Daad Akbar, Saudi Arabia
To determine the frequency of type-2 diabetics who have target lipoprotein blood levels and to study these levels in-patients with ischemic heart disease and cardiovascular disease risk factors we reviewed hyperlipdemic type-2 diabetics who were on regular follow up to the medical outpatient clinic of King abdulaziz University Hospital from January 2000 to January 2001. A total of 202 patients were studied with mean age of 60 years and equal male to female ratio. The mean duration of diabetes was 10 years and it was 7 years for hyperlipidemia. The mean level of LDL was 3.15 mmol/l and it was 1.0 mmol/l and 2.47 mmol/l for LDL and TG respectively. Only 31% of patients had LDL<2.6 mmol/l, 28% had HDL >1.1 mmol/l and 37% had TG <1.7 mmol/l. No significant difference was found in the frequency of target level of LDL in-patients with IHD and those without; 26% versus 34% (0.4). Similarly, no difference was found in those with hypertension, obesity, and patients with family history of IHD compared to those without these risk factors; 30%, 26%, 16% versus 34%, 36%, 33% (p0.2, 0.1,0.4 respectively). Males were found to have a higher frequency of target LDL level compared to females; 38% versus 25% (p 0.04). In conclusion, a low frequency of type-2diabetics has target levels of lipoproteins. Diabetics with IHD and CVD risk factors have also poor lipid control.
OnlineDiabetes
Journal, All rights reserved
|